5 02, 2016

FGEP and other Latin American organizations requested a Thematic Hearing at the Inter-American Commission on Human Rights

2018-02-05T10:36:13-03:00viernes, 5 febrero, 2016|Advocacy, Direct Action, Hepatitis C, HIV, Medicines, Public Health, RedLAM|

Por: Julia Varela   GEP Foundation (FGEP), along with more than 20 other civil society organizations from different countries in Latin America committed to defending the right to health, requested last January 18th a Thematic Hearing at the Inter-American Commission on Human Rights (IACHR) on the issue of lack of access to medicines. The request

10 11, 2015

Regulatory Agency in Argentina approved sofosbuvir and a local pharmaceutical company announced the entry into the market of its generic version

2015-11-14T16:07:28-03:00martes, 10 noviembre, 2015|Hepatitis C, Medicines, Patent opposition, Sofosbuvir|

Buenos Aires, November 10, 2015 - Argentine Medicines Regulatory Agency, ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica) approved last week commercialization of a relevant medicine to treat Hepatitis C. “This measure was highly expected since it is the first step to ensure availability of this essential medicine in our country. I live with Hepatitis

27 08, 2015

People living with HepC denounced high prices of the pharmaceutical industry

2015-11-04T20:18:54-03:00jueves, 27 agosto, 2015|Direct Action, Hepatitis C, Intellectual Property, Patent opposition, Public Health|

Buenos Aires, August 27th 2015 - Members of Grupo Efecto Positivo Foundation (FGEP) accompanied by other civil society organizations and representatives held a direct action during the 2015 Hepatitis International Symposium organized by Fundación Huesped. The action aimed to denounce monopolies and high prices of drugs to treat hepatitis C and took place during the presentation of Dr.

29 07, 2015

World Viral Hepatitis Day: Challenges and Progress in Argentina for access to treatments that cure

2015-11-04T14:06:31-03:00miércoles, 29 julio, 2015|Access to Medicines, Advocacy, Hepatitis C, Intellectual Property, Ministry of Health, Public Health|

BUENOS AIRES - On World Viral Hepatitis Day, Fundación Grupo Efecto Positivo (FGEP) held a meeting with officials from Argentina’s Ministry of Health, articulating and coordinating actions and strategies that promote access to sofosbuvir, an essential drug for Hepatitis C treatment. The need for joint action originates from the great challenge both Argentina and Latin

2 07, 2015

International Forum: Access to HIV and Hepatitis C Medicines

2015-10-30T18:02:25-03:00jueves, 2 julio, 2015|Access to Medicines, Capacity Building, Hepatitis C, HIV, Intellectual Property, RedLAM|

Citizens, organizations and experts analyzed the current challenges to hep C and HIV medicine’s access at the International Forum organized by RedLAM Citizens, NGO’s, experts and national authorities of Latin-American Countries exchanged ideas and strategic courses of action to boost Access to medicines at the “International Forum about Access to Medicines, Intellectual Property and Local

20 05, 2015

Patent opposition for Sofosbuvir requested in Argentina

2015-11-04T16:41:16-03:00miércoles, 20 mayo, 2015|Access to Medicines, Advocacy, Health Safeguards, Hepatitis C, Public Health|

Organizations of people with hepatitis C have filed an opposition for a patent that would prevent 800,000 people from having access to treatment in Argentina Fundación Grupo Efecto Positivo (FGEP) leads the opposition to pharmaceutical patents movement as a key strategy to ensure access to medicines The growing global movement to guarantee access to medicines

Ir a Arriba